How Has the Digital Diabetes Management Market Evolved Historically and What is its Current Size?
The digital diabetes management market has seen considerable growth due to a variety of factors.
• The market size for digital diabetes management has seen substantial expansion in the recent past. The market, estimated to stand at $15.9 billion in 2024, is projected to escalate to $19.27 billion in 2025, growing at a compound annual growth rate (CAGR) of 21.2%.
The notable growth during the historical phase can be credited to increasing instances of diabetes, advancements in technology, customization in healthcare, regulatory assistance, telehealth and remote monitoring services.
What Does Future Hold for The Digital Diabetes Management Market By 2029?
The digital diabetes management market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, substantial escalation is anticipated in the digital diabetes management market size, with a projected worth of $47.21 billion in 2029.
This growth, estimated at a compound annual growth rate (CAGR) of 25.1%, can be ascribed to several factors such as the ongoing diabetes pandemic, developments in artificial intelligence (AI) and machine learning, data integration, and remote care models. Key trends during this forecast period are likely to encompass continuous glucose monitoring (CGM), insulin delivery systems, mobile applications and wearable devices, and initiatives aimed at patient engagement and education.
What Are The Primary Growth Drivers In The Digital Diabetes Management Market?
The rising incidence of diabetes is anticipated to drive the need for digital diabetes management gadgets and associated services, thereby amplifying the market's demand. Diabetes is a prime cause of mortality, leading to a 30% reduction in life expectancy upon diagnosis. As per NHS England, a government agency based in the UK, there has been about a 25% surge in the count of individuals under 40 at risk for type 2 diabetes between 2022 and 2024, with numbers climbing from 173,166 in 2022 to 216,440 in 2023. Hence, this exacerbating progression of diabetes is triggering the demand for digital diabetes control.
What Is The Segmentation Of The Global Digital Diabetes Management Market?
The digital diabetes management market covered in this report is segmented –
1) By Product And Service: Devices, Application, Data Management Software And Platforms, Services
2) By Device Type: Handheld Devices, Wearable Devices
3) By End User: Self Or Home Healthcare, Hospitals And Specialty Diabetes Clinics, Other End Users
Subsegments:
1) By Devices: Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGM), Insulin Pumps, Smart Insulin Pens, Diabetes Testing Strips
2) By Application: Diabetes Management Apps, Lifestyle And Diet Management Apps, Glucose Tracking Apps, Insulin Dose Adjustment Apps, Exercise And Activity Tracking Apps
3) By Data Management Software And Platforms: Cloud-Based Diabetes Management Platforms, Data Analytics Platforms, Electronic Health Record (EHR) Integrated Systems, Patient Management Software, Remote Monitoring Software
4) By Services: Telemedicine And Virtual Consultation Services, Remote Monitoring Services, Diabetes Education Services, Diabetes Coaching And Support Services, Clinical Decision Support Services
Pre-Book The Digital Diabetes Management Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Digital Diabetes Management Market?
A growing number of businesses are putting more emphasis on creating design-centric and AI-integrated applications to improve user experience, a trend that is becoming increasingly prevalent in the digital diabetes management market. Major players in this market, such as OneDrop, Ascencia, and Dario, are shifting their approach to developing their products to be more like fashionable gadgets rather than traditional medical devices. For example, Medtronic plc and IBM Watson Health have launched the AI-enabled Sugar.IQ smart diabetes management app, which aims to enhance and streamline daily diabetes management.
Who Are the Key Players In The Digital Diabetes Management Market?
Major companies operating in the digital diabetes management market include:
• Bayer AG
• Medtronic Plc
• Roche Diagnostics Ltd.
• Dexcom Inc.
• Abbott Laboratories
• Ascensia Diabetes Care Holdings AG
• Insulet Corporation
• B. Braun Melsungen AG
• Tandem Diabetes Care Inc.
• LifeScan Inc.
• AgaMatrix Inc.
• Glooko Inc.
• DarioHealth Corp
• One Drop
• Dottli Oy
• Ypsomed Holding AG
• ARKRAY Inc.
• ACON Laboratories Inc.
• Becton
• Dickinson and Company
• Care Innovations LLC
• Health2Sync Inc.
• Emperra GmbH E-Health Technologies
• Azumio Inc.
• Decide Clinical Software GmbH
• pendiq GmbH Moers
• Health Arx Technologies Pvt Ltd.
• Sanofi SA
• Johnson & Johnson Co
• Novo Nordisk AS
• Terumo Corporation
• TidePool
• AgaMatrix Medical Devices Ltd.
What Are The Regional Insights Into The Digital Diabetes Management Market?
North America was the largest region in the digital diabetes management market in 2023. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
